Rapid screening of 2‐benzylbenzimidazole nitazene analogs in suspect counterfeit tablets using Raman, SERS, DART‐TD‐MS, and FT‐IR

Developing methods to rapidly screen for novel synthetic 2‐benzylbenzimidazole opioids, also known as nitazenes, has become increasingly important due to their high potency. These compounds have potency comparable or exceeding that of fentanyl by up to 10 times and have been implicated in approximat...

Full description

Saved in:
Bibliographic Details
Published in:Drug testing and analysis Vol. 15; no. 5; pp. 539 - 550
Main Authors: Kimani, Martin M., Kern, Sara, Lanzarotta, Adam, Thatcher, Michael, Lorenz, Lisa M., Smith, Skyler W., Collins, Melissa, Howe, Gregory W., Wetherby, Anthony E.
Format: Journal Article
Language:English
Published: England Wiley Subscription Services, Inc 01-05-2023
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Developing methods to rapidly screen for novel synthetic 2‐benzylbenzimidazole opioids, also known as nitazenes, has become increasingly important due to their high potency. These compounds have potency comparable or exceeding that of fentanyl by up to 10 times and have been implicated in approximately 5% of all drug overdose deaths in the United States in 2021. This paper details the authenticity determination of suspect tablets and the identification of three nitazene analogs (N‐pyrrolidino etonitazene, isotonitazene, and etodesnitazene) in suspect tablets seized at a mail facility using Raman and surface‐enhanced Raman scattering (SERS) with handheld devices, portable Fourier transform infrared spectrometer (FT‐IR), and a direct analysis in real‐time ambient ionization coupled to a thermal desorption unit and a mass spectrometer (DART‐TD‐MS). These methods are rapid and excellent for screening opioids in suspect tablets but could not fully determine the exact structure of some of the nitazene analogs present due to spectral similarities or similar fragmentation patterns. Liquid chromatography–mass spectrometry (LC–MS) confirmed the presence of these nitazene compounds in addition to other opioids/drugs that were in trace quantities. The quantitative high‐performance liquid chromatography coupled with ultraviolet (HPLC‐UV) detection experiments determined that the suspect tablets contained an average of 0.817 mg of N‐pyrrolidino etonitazene per tablet. The results obtained reveal that the simultaneous deployment of these complementary and orthogonal portable analytical techniques as part of a workflow allows suspect tablets to be screened and nitazene‐type drugs to be identified in suspect counterfeit tablets at remote sampling sites. The authenticity determination of suspect tablets and the identification nitazene‐type opioids such as N‐pyrrolidino etonitazene, isotonitazene, and etodesnitazene in these tablets collected at an International Mail Facility was accomplished using a portable device toolkit. This device toolkit consisted of a handheld Raman spectrometer utilizing surface enhanced Raman scattering (SERS), a portable Fourier transform infrared (FT‐IR) spectrometer, and a direct analysis in real‐time ambient ionization coupled to a thermal desorption unit and a mass spectrometer (DART‐TD‐MS).
Bibliography:DISCLAIMER: The contents of this manuscript are the author's opinions and should not be considered as opinions or policy of the US FDA. The mention of trade names and manufacturers is for technical accuracy and should not be considered as endorsement of a specific product or manufacturer.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1942-7603
1942-7611
DOI:10.1002/dta.3440